Search results for ERBB

C-erbB-3/HER3 Antibody (YA6013), MedChemexpress, HY-P86321

C-erbB-3/HER3 Antibody (YA6013) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to C-erbB-3/HER3.

C-erbB-2/HER2 Antibody (YA6411), MedChemexpress, HY-P86719

C-erbB-2/HER2 Antibody (YA6411) is a Mouse-derived and non-conjugated IgG monoclonal antibody, targeting to C-erbB-2/HER2.

C-erbB-3/HER3 Antibody (YA3880), MedChemexpress, HY-P84183

C-erbB-3/HER3 Antibody (YA3880) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to C-erbB-3/HER3.

HRP Anti-ErbB 3 antibody [SP71], Abcam, AB306104

This conjugated primary antibody is "made to order" and it is released using a quantitative quality control method that ensures binding affinity and labelling efficiency of the conjugate. Via leveraging the power of the Lightning-Link ® conjugation technology , Abcam will deliver highly consistent recombinant conjugates in <2 weeks, giving you access to an ever growing portfolio of antibody-label combinations. For suitable applications and species reactivity, please refer to the unconjugated version of this clone. How are conjugated primary antibodies validated? This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling. For suitable applications and species reactivity, please refer to the unconjugated version of this clone. Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

PE Anti-ErbB 3 antibody [SP71], Abcam, AB306102

This conjugated primary antibody is "made to order" and it is released using a quantitative quality control method that ensures binding affinity and labelling efficiency of the conjugate. Via leveraging the power of the Lightning-Link ® conjugation technology , Abcam will deliver highly consistent recombinant conjugates in <2 weeks, giving you access to an ever growing portfolio of antibody-label combinations. For suitable applications and species reactivity, please refer to the unconjugated version of this clone. How are conjugated primary antibodies validated? This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling. For suitable applications and species reactivity, please refer to the unconjugated version of this clone. Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

C-erbB-2/HER2 Monoclonal Antibody, Bioss, bsm-33051m

C-erbB-2/HER2 Monoclonal Antibody, Bioss, bsm-33085m

C-erbB-2/HER2 Antibody (YA771), MedChemexpress, HY-P80658

C-erbB-2/HER2 Antibody (YA771) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to C-erbB-2/HER2.

C-erbB-3/HER3 Antibody (YA457), MedChemexpress, HY-P80659

C-erbB-3/HER3 Antibody (YA457) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to C-erbB-3/HER3.

C-erbB-4/HER4 Antibody (YA456), MedChemexpress, HY-P80660

C-erbB-4/HER4 Antibody (YA456) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to C-erbB-4/HER4.